Migraine Trial, Recruiting NCT07567300 Sponsor: Bozok University Condition: Migraine
Back to Migraine

Migraine Trial, Recruiting

NCT07567300
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are between 18 and 65 years old
  • People who are able to read and understand Turkish
  • People who agree to take part voluntarily
  • People who have been diagnosed with episodic or chronic migraine, based on the International Classification of Headache Disorders (3rd edition) criteria
  • People who also experience neck pain and/or lower back pain that does not have a separate formal diagnosis explaining it

Who may not be able to join:

  • People who have a history of a neurological condition, such as Multiple Sclerosis
  • People who have an inflammatory joint or autoimmune condition, such as Rheumatoid Arthritis
  • People who have a widespread chronic pain condition, such as Fibromyalgia
  • People who have any other type of headache disorder, or any other ongoing systemic illness
  • People who have an acute (recent/active) bone fracture or active infection
  • People who have had spinal surgery or been diagnosed with a spinal disease in the last 6 months
  • People who have experienced a serious musculoskeletal injury in the last 6 months
  • People who are currently pregnant
  • People who have a cognitive or psychiatric condition that would make completing questionnaires difficult
  • People in the control group who do not have a migraine diagnosis (confirm with trial site)
  • People who have a history of recurring headaches within the last year (confirm with trial site, as this may interact with the migraine diagnosis criteria)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Merve Ceren Akgör, Neurologist, Department of Neurology, University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital, Ankara, Türkiye

Phone: +905358642234

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Bozok University
Registry
ClinicalTrials.gov
Start date
30 April 2026
Est. completion
17 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Central Sensitization Inventory

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov